vs

Side-by-side financial comparison of Constellation Brands (STZ) and UPBOUND GROUP, INC. (UPBD). Click either name above to swap in a different company.

Constellation Brands is the larger business by last-quarter revenue ($2.2B vs $1.2B, roughly 1.9× UPBOUND GROUP, INC.). Constellation Brands runs the higher net margin — 22.6% vs 1.7%, a 21.0% gap on every dollar of revenue. On growth, UPBOUND GROUP, INC. posted the faster year-over-year revenue change (10.9% vs -9.8%). Constellation Brands produced more free cash flow last quarter ($370.9M vs $24.0M). Over the past eight quarters, UPBOUND GROUP, INC.'s revenue compounded faster (4.5% CAGR vs 1.9%).

Constellation Brands, Inc. is an American producer and marketer of beer, wine, and spirits. A Fortune 500 company, Constellation is the largest beer import company in the US, measured by sales, and has the third-largest market share of all major beer suppliers. It also has sizable investments in medical and recreational cannabis through its association with Canopy Growth. Based in Rochester, New York, Constellation has about 40 facilities and approximately 9,000 employees.

Upbound Group, Inc. is a leading US provider of flexible lease-to-own solutions for consumer goods. It offers furniture, consumer electronics, home appliances, and accessories, catering to customers seeking accessible payment alternatives to traditional retail financing.

STZ vs UPBD — Head-to-Head

Bigger by revenue
STZ
STZ
1.9× larger
STZ
$2.2B
$1.2B
UPBD
Growing faster (revenue YoY)
UPBD
UPBD
+20.6% gap
UPBD
10.9%
-9.8%
STZ
Higher net margin
STZ
STZ
21.0% more per $
STZ
22.6%
1.7%
UPBD
More free cash flow
STZ
STZ
$346.9M more FCF
STZ
$370.9M
$24.0M
UPBD
Faster 2-yr revenue CAGR
UPBD
UPBD
Annualised
UPBD
4.5%
1.9%
STZ

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
STZ
STZ
UPBD
UPBD
Revenue
$2.2B
$1.2B
Net Profit
$502.8M
$19.7M
Gross Margin
53.2%
49.0%
Operating Margin
31.1%
4.8%
Net Margin
22.6%
1.7%
Revenue YoY
-9.8%
10.9%
Net Profit YoY
-18.4%
-36.3%
EPS (diluted)
$0.35

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
STZ
STZ
UPBD
UPBD
Q4 25
$2.2B
$1.2B
Q3 25
$2.5B
$1.2B
Q2 25
$2.5B
$1.2B
Q1 25
$2.2B
$1.2B
Q4 24
$2.5B
$1.1B
Q3 24
$2.9B
$1.1B
Q2 24
$2.7B
$1.1B
Q1 24
$2.1B
$1.1B
Net Profit
STZ
STZ
UPBD
UPBD
Q4 25
$502.8M
$19.7M
Q3 25
$466.0M
$13.2M
Q2 25
$516.1M
$15.5M
Q1 25
$-375.3M
$24.8M
Q4 24
$615.9M
$31.0M
Q3 24
$-1.2B
$30.9M
Q2 24
$877.0M
$33.9M
Q1 24
$392.4M
$27.7M
Gross Margin
STZ
STZ
UPBD
UPBD
Q4 25
53.2%
49.0%
Q3 25
52.8%
48.3%
Q2 25
50.4%
49.4%
Q1 25
51.5%
46.8%
Q4 24
52.1%
47.1%
Q3 24
51.8%
47.8%
Q2 24
52.7%
49.4%
Q1 24
48.6%
48.3%
Operating Margin
STZ
STZ
UPBD
UPBD
Q4 25
31.1%
4.8%
Q3 25
35.2%
4.5%
Q2 25
28.4%
4.4%
Q1 25
-6.9%
5.3%
Q4 24
32.2%
7.3%
Q3 24
-42.1%
6.6%
Q2 24
35.4%
7.5%
Q1 24
29.4%
5.6%
Net Margin
STZ
STZ
UPBD
UPBD
Q4 25
22.6%
1.7%
Q3 25
18.8%
1.1%
Q2 25
20.5%
1.3%
Q1 25
-17.3%
2.1%
Q4 24
25.0%
2.9%
Q3 24
-41.1%
2.9%
Q2 24
32.9%
3.2%
Q1 24
18.3%
2.5%
EPS (diluted)
STZ
STZ
UPBD
UPBD
Q4 25
$0.35
Q3 25
$0.22
Q2 25
$0.26
Q1 25
$0.42
Q4 24
$0.55
Q3 24
$0.55
Q2 24
$0.61
Q1 24
$0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
STZ
STZ
UPBD
UPBD
Cash + ST InvestmentsLiquidity on hand
$152.4M
$120.5M
Total DebtLower is stronger
$10.3B
Stockholders' EquityBook value
$7.7B
$695.7M
Total Assets
$21.7B
$3.3B
Debt / EquityLower = less leverage
1.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
STZ
STZ
UPBD
UPBD
Q4 25
$152.4M
$120.5M
Q3 25
$72.0M
$107.0M
Q2 25
$73.9M
$106.8M
Q1 25
$68.1M
$107.3M
Q4 24
$73.7M
$60.9M
Q3 24
$64.6M
$85.1M
Q2 24
$73.8M
$82.5M
Q1 24
$152.4M
$84.8M
Total Debt
STZ
STZ
UPBD
UPBD
Q4 25
$10.3B
Q3 25
$10.3B
Q2 25
$11.2B
Q1 25
$10.7B
Q4 24
$10.7B
Q3 24
$11.1B
Q2 24
$11.1B
Q1 24
$11.6B
Stockholders' Equity
STZ
STZ
UPBD
UPBD
Q4 25
$7.7B
$695.7M
Q3 25
$7.5B
$687.3M
Q2 25
$7.3B
$685.5M
Q1 25
$6.9B
$679.2M
Q4 24
$7.8B
$629.0M
Q3 24
$7.9B
$611.8M
Q2 24
$10.3B
$596.3M
Q1 24
$9.7B
$578.3M
Total Assets
STZ
STZ
UPBD
UPBD
Q4 25
$21.7B
$3.3B
Q3 25
$21.4B
$3.2B
Q2 25
$22.3B
$3.1B
Q1 25
$21.7B
$3.0B
Q4 24
$22.8B
$2.6B
Q3 24
$23.1B
$2.6B
Q2 24
$26.1B
$2.6B
Q1 24
$25.7B
$2.6B
Debt / Equity
STZ
STZ
UPBD
UPBD
Q4 25
1.33×
Q3 25
1.37×
Q2 25
1.54×
Q1 25
1.55×
Q4 24
1.37×
Q3 24
1.41×
Q2 24
1.08×
Q1 24
1.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
STZ
STZ
UPBD
UPBD
Operating Cash FlowLast quarter
$616.9M
$41.6M
Free Cash FlowOCF − Capex
$370.9M
$24.0M
FCF MarginFCF / Revenue
16.7%
2.0%
Capex IntensityCapex / Revenue
11.1%
1.5%
Cash ConversionOCF / Net Profit
1.23×
2.11×
TTM Free Cash FlowTrailing 4 quarters
$1.8B
$238.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
STZ
STZ
UPBD
UPBD
Q4 25
$616.9M
$41.6M
Q3 25
$852.1M
$118.4M
Q2 25
$637.2M
$7.8M
Q1 25
$594.7M
$137.7M
Q4 24
$685.2M
$-61.9M
Q3 24
$1.2B
$106.2M
Q2 24
$690.5M
$15.0M
Q1 24
$433.2M
$45.4M
Free Cash Flow
STZ
STZ
UPBD
UPBD
Q4 25
$370.9M
$24.0M
Q3 25
$634.8M
$97.9M
Q2 25
$444.4M
$-10.4M
Q1 25
$312.1M
$127.2M
Q4 24
$456.8M
$-74.0M
Q3 24
$854.0M
$88.3M
Q2 24
$315.2M
$613.0K
Q1 24
$76.0M
$33.6M
FCF Margin
STZ
STZ
UPBD
UPBD
Q4 25
16.7%
2.0%
Q3 25
25.6%
8.4%
Q2 25
17.7%
-0.9%
Q1 25
14.4%
10.8%
Q4 24
18.5%
-6.9%
Q3 24
29.3%
8.3%
Q2 24
11.8%
0.1%
Q1 24
3.6%
3.1%
Capex Intensity
STZ
STZ
UPBD
UPBD
Q4 25
11.1%
1.5%
Q3 25
8.8%
1.8%
Q2 25
7.7%
1.6%
Q1 25
13.1%
0.9%
Q4 24
9.3%
1.1%
Q3 24
11.2%
1.7%
Q2 24
14.1%
1.3%
Q1 24
16.7%
1.1%
Cash Conversion
STZ
STZ
UPBD
UPBD
Q4 25
1.23×
2.11×
Q3 25
1.83×
8.96×
Q2 25
1.23×
0.50×
Q1 25
5.56×
Q4 24
1.11×
-2.00×
Q3 24
3.44×
Q2 24
0.79×
0.44×
Q1 24
1.10×
1.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

STZ
STZ

Beer$2.0B90%
Constellation Wines And Spirits$213.1M10%

UPBD
UPBD

Segment breakdown not available.

Related Comparisons